scholarly journals Transarterial embolization in acute colonic bleeding: review of 11 years of experience and long-term results

2012 ◽  
Vol 28 (6) ◽  
pp. 777-782 ◽  
Author(s):  
Andrea Rossetti ◽  
Nicolas C. Buchs ◽  
Romain Breguet ◽  
Pascal Bucher ◽  
Sylvain Terraz ◽  
...  
2011 ◽  
Vol 2011 ◽  
pp. 1-7 ◽  
Author(s):  
Boris Chertin ◽  
Stanislav Kocherov ◽  
Leonid Chertin ◽  
Alaeddin Natsheh ◽  
Amicur Farkas ◽  
...  

Purpose. We reviewed our 20 years of experience and the current literature regarding the long-term outcome of endoscopic treatment of vesicoureteric reflux (VUR) using the different tissue bulking substances with a special emphasis on the long-term efficacy.Material and Methods. Our own experience and the current literature on the long-term results after endoscopic treatment using various bulking agents were reviewed.Results. Short-term data following endoscopic treatment of VUR is similar to the various substances and comparable in the majority of the series to the success rate following open surgery. Recently, a relatively high recurrence rate was noticed especially with the use of dextranomer hyaluronic acid (Dx/HA) as a tissue augmenting material which raises the need for further search for alternative substances.Conclusions. Unfortunately, there is a significant shortage of evidence-based literature on the long-term followup after endoscopic correction of reflux with various substances. No doubt, there is a high recurrence rate during long-term followup after Dx/HA injection, and there is probably lack of proper evaluation regarding the long-term efficacy of other bulking materials. These facts demand long-term close observation and long-term studies beyond the routine protocols following endoscopic treatment of VUR and the correct parental counseling upon the endoscopic correction.


Eye ◽  
2016 ◽  
Vol 31 (3) ◽  
pp. 372-378 ◽  
Author(s):  
S J Lang ◽  
D Böhringer ◽  
G Geerling ◽  
T Reinhard

2015 ◽  
Vol 8 (6) ◽  
pp. 626-635 ◽  
Author(s):  
Caterina Michelozzi ◽  
Anne Christine Januel ◽  
Victor Cuvinciuc ◽  
Philippe Tall ◽  
Fabrice Bonneville ◽  
...  

ObjectTo report the morbidity and long term results in the treatment of paragangliomas by transarterial embolization with ethylene vinyl alcohol (Onyx), either as preoperative or palliative treatment.MethodsBetween September 2005 and 2012, 18 jugulotympanic, 7 vagal, and 4 carotid body paragangliomas (CBPs) underwent Onyx embolization, accordingly to our head and neck multidisciplinary team's decision. CBPs were embolized preoperatively. Jugulotympanic and vagal paragangliomas underwent surgery when feasible, otherwise palliative embolization was carried out alone, or in combination with radiotherapy or tympanic surgery in the case of skull base or tympanic extension. Treatment results, and clinical and MRI follow-up data were recorded.ResultsIn all cases, devascularization of at least 60% of the initial tumor blush was obtained; 6 patients underwent two embolizations. Post-embolization, 8 patients presented with cranial nerve palsy, with partial or complete regression at follow-up (mean 31 months, range 3–86 months), except for 2 vagal and 1 hypoglossal palsy. 10 patients were embolized preoperatively; 70% were cured after surgery and 30% showed residual tumor. 19 patients received palliative embolization, of whom 5 underwent radiotherapy and 3 received tympanic surgery post-embolization. Long term follow-up of palliative embolization resulted in tumor volume stability (75%) or extension in intracranial or tympanic compartments. Onyx embolization of CBPs resulted in more difficult surgical dissection in 2 of 4 cases.ConclusionsOnyx embolization is a valuable alternative to surgery in the treatment of jugulotympanic and vagal paragangliomas; tympanic surgery or radiosurgery of the skull base should be considered in selected cases. Preoperative Onyx embolization of CBPs is not recommended.


1996 ◽  
Vol 84 (3) ◽  
pp. 400-404 ◽  
Author(s):  
Adam I. Lewis ◽  
Thomas A. Tomsick ◽  
John M. Tew ◽  
Michael A. Lawless

✓ Transarterial embolization of direct carotid—cavernous fistulas (CCFs) using detachable balloons is the best initial option for occlusion of the fistula and preservation of the internal carotid artery. However, the long-term safety and efficacy of this treatment is unknown. The authors reviewed the long-term outcome of 87 patients with 88 direct CCFs occluded by detachable balloons. Clinical follow up was obtained in 48 (83%) of 58 patients treated with latex balloons (mean follow-up period 10 years, range 5.9–15.5 years) and 28 (97%) of 29 patients treated with silicone balloons (mean follow-up period 4 years, range 1–6.6 years). Two patients were treated with both balloon types. There were no late recurrent symptoms of cranial bruit, proptosis, chemosis, or arterialized conjunctiva in patients treated with either latex or silicone balloons. Diplopia improved in all patients; however, five patients required shortening of the lateral rectus muscle. Delayed ischemia occurred in three patients: one patient had a transient ischemic episode 5 years after treatment with latex balloons and two patients (85 and 90 years old) who had ruptured spontaneous intracavernous aneurysms suffered cerebral infarctions 6 weeks and 4 months, respectively, after treatment with silicone balloons. There were five deaths in the series unrelated to balloon treatment. These results show that after transarterial embolization of direct CCFs using either silicone or latex detachable balloons, the long-term risks are low for fistula recurrence, symptomatic foreign body reaction, symptomatic pseudoaneurysm formation, and cerebral ischemia.


2012 ◽  
Vol 61 (3) ◽  
pp. 133-138 ◽  
Author(s):  
Naoto Morimoto ◽  
Syunsuke Matsushima ◽  
Masaya Aoki ◽  
Soichiro Henmi ◽  
Naritomo Nishioka ◽  
...  

2003 ◽  
Vol 180 (5) ◽  
pp. 1379-1384 ◽  
Author(s):  
Christian Loewe ◽  
Martin Schindl ◽  
Manfred Cejna ◽  
Bruno Niederle ◽  
Johannes Lammer ◽  
...  

2020 ◽  
pp. 1-5
Author(s):  
Evi Comploj ◽  
Alexander Pycha ◽  
Emanuela Trenti ◽  
Salvatore Palermo ◽  
Matteo Bonatti ◽  
...  

<b><i>Introduction:</i></b> The purpose of this study was to evaluate the effectiveness and long-term results of selective transarterial iliac embolization (STIE) in patients with intractable bladder haemorrhage (IBH). <b><i>Methods:</i></b> Twenty-five patients with a median age of 84 (range 65–94) years underwent STIE because of IBH between 2002 and 2020. The median follow-up time was 3 (mean 13.9) months. Patients were treated because of bleeding bladder or prostate cancer, radiation-induced haemorrhagic cystitis, and other conditions. Success was defined as technical success (feasibility to embolize bilateral hypogastric arteries or neoplastic arteries) and as clinical success (absence of further or additional therapy). <b><i>Results:</i></b> Twenty-five patients with a median age of 84 years with a median hospital stay of 7 days were embolized at our institution. In total, 60% required additional therapy. Only 20% had minor complications, but no complication major was seen; 60% needed an additional therapy because of continuous bleeding. Our 30-day, 90-day, 6-month, and 12-month mortality rates were 28, 44, 64, and 76%, respectively. <b><i>Conclusions:</i></b> STIE in IBH is a safe, well-tolerated, and feasible procedure for palliating haematuria patients in poor general condition. Major complications are very rarely seen. However, patients often need additional therapy after STIE.


Sign in / Sign up

Export Citation Format

Share Document